Life Science Investing News, Stocks, Forecasts and Analysis

Gloved hand holds a cluster of brown mushrooms growing from a gray substrate block.

Psychedelics Market Trends: H1 2026 Review and Forecast

As federal policies shift, the psychedelic medicine market is transitioning from speculative research to a prescription-oriented framework. Could 2026 be a breakthrough year for psychedelic therapies?

Psychedelics Investing

Investing News NetworkYour trusted source for investing success

Life Science Investing

Psychedelics Market Trends: H1 2026 Review and Forecast

5 Best-performing Canadian Pharma Stocks in 2026

Biotech and Pharma Market Trends: Q2 2026 Review and Forecast

Top 5 Small-cap Biotech Stocks in 2026

Eli Lilly to Buy Psychedelics Firm AtaiBeckley for US$2.8 Billion

Zymeworks Expands into Respiratory Market with Theravance Buyout

Merck KGaA to Acquire Bio-Techne in US$11.3 Billion Deal

BriaCell Therapeutics

Lexaria Bioscience

BriaCell Opens First Canadian Site - Sunnybrook - for Pivotal Phase 3 Trial in Metastatic Breast Cancer

BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT

BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT

Lexaria Updates Business Development

Lexaria Updates Business Development

Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule

BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT

Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule

GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand

GLP-1 "Arms Race" Intensifies as the Addressable Markets Continue to Expand

Government approvals secured for the use of Galidesivir as a treatment for Bundibugyo Ebola epidemic in Africa

Emyria Launches Global Services Platform Targeting International Drug Sponsors

Amplia Therapeutics Reports Four Additional Complete Responses and Improved Overall Survival Data in Accent Pancreatic Cancer Trial

Seegnal Presents Real-World Evidence on Reducing Fall Risk in Geriatric Patients at Caltcm Summit

Expansion of SVN-015 into Depression Following Positive Preclinical Data

Executive Order Sparks New Phase for Psychedelic Biotech, but Risks Remain

Biotech and Pharma Market Update: Q1 2026 in Review

Psychedelics Market Forecast: Top Trends for Psychedelics in 2026

Latest life science News

Outlook Reports world

Featured Life Science Investing Stocks

BriaCell Therapeutics

Lexaria Bioscience

Prime Medicine

BPH Energy: Fueling Innovation

ResMed

Staar Surgical

Browse Companies